Search

Your search keyword '"Irie, Yuhei"' showing total 39 results
Start Over Author "Irie, Yuhei"
39 results on '"Irie, Yuhei"'

2. Net reclassification index in comparison of prognostic value of disseminated intravascular coagulation diagnostic criteria by Japanese Society on Thrombosis and Hemostasis and International Society on Thrombosis and Haemostasis: a multicenter prospective cohort study

Author

Mori, Hirotaka, Harada-Shirado, Kayo, Kawano, Noriaki, Hayakawa, Mineji, Seki, Yoshinobu, Uchiyama, Toshimasa, Yamakawa, Kazuma, Ishikura, Hiroyasu, Irie, Yuhei, Nishio, Kenji, Yada, Noritaka, Okamoto, Kohji, and Ikezoe, Takayuki

Published
2023
Full Text
View/download PDF

3. The Restrictive Red Blood Cell Transfusion Strategy for Critically Injured Patients (RESTRIC) trial: a cluster-randomized, crossover, non-inferiority multicenter trial of restrictive transfusion in trauma

Author

Hayakawa, Mineji, Tagami, Takashi, Kudo, Daisuke, Ono, Kota, Aoki, Makoto, Endo, Akira, Yumoto, Tetsuya, Matsumura, Yosuke, Irino, Shiho, Sekine, Kazuhiko, Ushio, Noritaka, Ogura, Takayuki, Nachi, Sho, Irie, Yuhei, Hayakawa, Katsura, Ito, Yusuke, Okishio, Yuko, Muronoi, Tomohiro, Kosaki, Yoshinori, Ito, Kaori, Nakatsutsumi, Keita, Kondo, Yutaka, Ueda, Taichiro, Fukuma, Hiroshi, Saisaka, Yuichi, Tominaga, Naoki, Kurita, Takeo, Nakayama, Fumihiko, Shibata, Tomotaka, and Kushimoto, Shigeki

Published
2023
Full Text
View/download PDF

5. Correction: Prognostic value of plasma high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study

Author

Mori, Hirotaka, Kataoka, Yuki, Harada-Shirado, Kayo, Kawano, Noriaki, Hayakawa, Mineji, Seki, Yoshinobu, Uchiyama, Toshimasa, Yamakawa, Kazuma, Ishikura, Hiroyasu, Irie, Yuhei, Nishio, Kenji, Yada, Noritaka, Okamoto, Kohji, Yamada, Shingo, and Ikezoe, Takayuki

Published
2022
Full Text
View/download PDF

10. Prognostic value of plasma high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study

Author

Mori, Hirotaka, primary, Kataoka, Yuki, additional, Harada-Shirado, Kayo, additional, Kawano, Noriaki, additional, Hayakawa, Mineji, additional, Seki, Yoshinobu, additional, Uchiyama, Toshimasa, additional, Yamakawa, Kazuma, additional, Ishikura, Hiroyasu, additional, Irie, Yuhei, additional, Nishio, Kenji, additional, Yada, Noritaka, additional, Okamoto, Kohji, additional, Yamada, Shingo, additional, and Ikezoe, Takayuki, additional

Published
2022
Full Text
View/download PDF

11. Additional file 8 of Prognostic value of serum high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study

Author

Mori, Hirotaka, Kataoka, Yuki, Harada-Shirado, Kayo, Kawano, Noriaki, Hayakawa, Mineji, Seki, Yoshinobu, Uchiyama, Toshimasa, Yamakawa, Kazuma, Ishikura, Hiroyasu, Irie, Yuhei, Nishio, Kenji, Yada, Noritaka, Okamoto, Kohji, Yamada, Shingo, and Ikezoe, Takayuki

Subjects
hemic and lymphatic diseases, chemical and pharmacologic phenomena
Abstract

Additional file 8: Supplementary Table S5. AUC of platelet counts, D-dimer, PT-INR, fibrinogen, ISTH DIC scores, HMGB1 and histone H3.

Published
2022
Full Text
View/download PDF

12. Additional file 3 of Prognostic value of serum high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study

Author

Mori, Hirotaka, Kataoka, Yuki, Harada-Shirado, Kayo, Kawano, Noriaki, Hayakawa, Mineji, Seki, Yoshinobu, Uchiyama, Toshimasa, Yamakawa, Kazuma, Ishikura, Hiroyasu, Irie, Yuhei, Nishio, Kenji, Yada, Noritaka, Okamoto, Kohji, Yamada, Shingo, and Ikezoe, Takayuki

Subjects
population characteristics, chemical and pharmacologic phenomena, social sciences, human activities, humanities
Abstract

Additional file 3: Supplementary Table S3. Serum HMGB1 and histone H3 levels between survivors and non-survivors by underlying disease types.

Published
2022
Full Text
View/download PDF

13. Additional file 1 of Prognostic value of serum high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study

Author

Mori, Hirotaka, Kataoka, Yuki, Harada-Shirado, Kayo, Kawano, Noriaki, Hayakawa, Mineji, Seki, Yoshinobu, Uchiyama, Toshimasa, Yamakawa, Kazuma, Ishikura, Hiroyasu, Irie, Yuhei, Nishio, Kenji, Yada, Noritaka, Okamoto, Kohji, Yamada, Shingo, and Ikezoe, Takayuki

Abstract

Additional file 1: Supplementary Table S1. STARD statement checklist.

Published
2022
Full Text
View/download PDF

14. Additional file 5 of Prognostic value of serum high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study

Author

Mori, Hirotaka, Kataoka, Yuki, Harada-Shirado, Kayo, Kawano, Noriaki, Hayakawa, Mineji, Seki, Yoshinobu, Uchiyama, Toshimasa, Yamakawa, Kazuma, Ishikura, Hiroyasu, Irie, Yuhei, Nishio, Kenji, Yada, Noritaka, Okamoto, Kohji, Yamada, Shingo, and Ikezoe, Takayuki

Abstract

Additional file 5: Supplementary Table S4. Underlying diseases of DIC.

Published
2022
Full Text
View/download PDF

15. Additional file 9 of Prognostic value of serum high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study

Author

Mori, Hirotaka, Kataoka, Yuki, Harada-Shirado, Kayo, Kawano, Noriaki, Hayakawa, Mineji, Seki, Yoshinobu, Uchiyama, Toshimasa, Yamakawa, Kazuma, Ishikura, Hiroyasu, Irie, Yuhei, Nishio, Kenji, Yada, Noritaka, Okamoto, Kohji, Yamada, Shingo, and Ikezoe, Takayuki

Abstract

Additional file 9: Supplementary Table S6. Category reclassification by HMGB1.

Published
2022
Full Text
View/download PDF

16. Additional file 2 of Prognostic value of serum high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study

Author

Mori, Hirotaka, Kataoka, Yuki, Harada-Shirado, Kayo, Kawano, Noriaki, Hayakawa, Mineji, Seki, Yoshinobu, Uchiyama, Toshimasa, Yamakawa, Kazuma, Ishikura, Hiroyasu, Irie, Yuhei, Nishio, Kenji, Yada, Noritaka, Okamoto, Kohji, Yamada, Shingo, and Ikezoe, Takayuki

Abstract

Additional file 2: Supplementary Table S2. ISTH DIC scoring system.

Published
2022
Full Text
View/download PDF

18. Prognostic Value of Serum High Mobility Group Box 1 Protein and Histone H3 Levels in Patients with Disseminated Intravascular Coagulation: A Multicenter Prospective Cohort Study

Author

Mori, Hirotaka, primary, Kataoka, Yuki, additional, Harada-Shirado, Kayo, additional, Kawano, Noriaki, additional, Hayakawa, Mineji, additional, Seki, Yoshinobu, additional, Uchiyama, Toshimasa, additional, Yamakawa, Kazuma, additional, Ishikura, Hiroyasu, additional, Irie, Yuhei, additional, Nishio, Kenji, additional, Yada, Noritaka, additional, Okamoto, Kohji, additional, Yamada, Shingo, additional, and Ikezoe, Takayuki, additional

Published
2022
Full Text
View/download PDF

19. Effects of evidence-based ICU care on long-term outcomes of patients with sepsis or septic shock (ILOSS): protocol for a multicentre prospective observational cohort study in Japan

Author

Liu, Keibun, primary, Kotani, Toru, additional, Nakamura, Kensuke, additional, Chihiro, Takai, additional, Morita, Yasunari, additional, Ishii, Kenzo, additional, Fujizuka, Kenji, additional, Yasumura, Daisetsu, additional, Taniguchi, Daisuke, additional, Hamagami, Tomohiro, additional, Shimojo, Nobutake, additional, Nitta, Masakazu, additional, Hongo, Takashi, additional, Akieda, Kazuki, additional, Atsuo, Maeda, additional, Kaneko, Tadashi, additional, Sakuda, Yutaka, additional, Andoh, Kohkichi, additional, Nagatomi, Akiyoshi, additional, Tanaka, Yukiko, additional, Irie, Yuhei, additional, Kamijo, Hiroshi, additional, Hanazawa, Manabu, additional, Kasugai, Daisuke, additional, Ayaka, Matsuoka, additional, Oike, Kenji, additional, Lefor, Alan Kawarai, additional, Takahashi, Kunihiko, additional, Katsukawa, Hajime, additional, and Ogura, Takayuki, additional

Published
2022
Full Text
View/download PDF

20. Early recognition of sepsis-induced coagulopathy using the C2PAC index: a ratio of soluble type C lectin-like receptor 2 (sCLEC-2) level and platelet count

Author

Ishikura, Hiroyasu, primary, Irie, Yuhei, additional, Kawamura, Masahide, additional, Hoshino, Kota, additional, Nakamura, Yoshihiko, additional, Mizunuma, Mariko, additional, Maruyama, Junichi, additional, Nakashio, Maiko, additional, Suzuki-Inoue, Katsue, additional, and Kitamura, Taisuke, additional

Published
2022
Full Text
View/download PDF

25. Usefulness of Early Diagnosis of Sepsis-Induced Coagulopathy by Measuring Novel Platelet Activation Marker Soluble Type C Lectin-Like Receptor 2 (CLEC-2)

Author

Ishikura, Hiroyasu, primary, Irie, Yuhei, additional, Kawamura, Masahide, additional, Hoshino, Kota, additional, Nakamura, Yoshihiko, additional, Mizunuma, Mariko, additional, Maruyama, Junichi, additional, Nakashio, Maiko, additional, Suzuki-Inoue, Katsue, additional, and Kitamura, Taisuke, additional

Published
2021
Full Text
View/download PDF

26. Characteristics of Coagulation/Fibrinolysis Abnormalities in Serious Corona Virus Disease 2019 (COVID-19) Patients Complicated with Stroke: Case Series

Author

Ishikura, Hiroyasu, primary, Maruyama, Junichi, additional, Izutani, Yoshito, additional, Morimoto, Shinichi, additional, Takayama, Kazushi, additional, Irie, Yuhei, additional, Kitamura, Taisuke, additional, Iwaasa, Mitsutoshi, additional, Hoshino, Kota, additional, and Nakamura, Yoshihiko, additional

Published
2020
Full Text
View/download PDF

38. Oral Health of COVID-19 Patients Using Extracorporeal Membrane Oxygenation: A Clinical Study of 19 Cases.

Author

Yoshino, Aya, Nakamura, Yoshihiko, Irie, Yuhei, Kitamura, Taisuke, Takata, Tohru, Ishikura, Hiroyasu, and Kondo, Seiji

Subjects
EXTRACORPOREAL membrane oxygenation, COVID-19, ORAL health, INTENSIVE care patients, BODY mass index
Abstract

The oral health of coronavirus disease 2019 (COVID-19) patients in the intensive care unit (ICU) is an important issue in treatment of respiratory failure. We retrospectively investigated the oral health history of severe COVID-19 patients who received extracorporeal membrane oxygenation (ECMO) from April 2020 to December 2020 using the oral assessment guide from Fukuoka University (OAG-F). Nineteen consecutive patients (median age: 62 years) were divided into two groups according to survival (survivors, n = 12; non-survivors, n = 7). A univariate analysis revealed no significant differences between the groups in sex, age, body mass index (BMI), or the number of remaining teeth, whereas the ECMO assistance of non-survivors (median: 34 days) was prolonged in comparison to survivors (median: 8 days; p < 0.05). Among the factors of OAG-F, significant differences were observed between the groups in the conditions of the saliva, mucous membrane, and gingiva. The total scores in non-survivors (median: 19) were significantly higher in comparison to survivors (Median: 15.5), suggesting that the frequency of oral health deterioration was higher in non-survivors (p < 0.05). Taken together, these findings suggest that poor oral health is associated with mortality in COVID-19 patients receiving ECMO in the ICU. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

39. Involvement of the cystathionine-γ-lyase/Ca v 3.2 pathway in substance P-induced bladder pain in the mouse, a model for nonulcerative bladder pain syndrome.

Author

Tsubota M, Okawa Y, Irie Y, Maeda M, Ozaki T, Sekiguchi F, Ishikura H, and Kawabata A

Subjects
Animals, Benzimidazoles pharmacology, Calcium Channel Blockers pharmacology, Calcium Channels, T-Type genetics, Cyclophosphamide toxicity, Cyclopropanes pharmacology, Cystathionine gamma-Lyase genetics, Disease Models, Animal, Dose-Response Relationship, Drug, Female, Ganglia, Spinal metabolism, Ganglia, Spinal pathology, Hyperalgesia drug therapy, Hyperalgesia etiology, Immunosuppressive Agents toxicity, Mice, Naphthalenes pharmacology, Oligodeoxyribonucleotides, Antisense administration & dosage, Pain chemically induced, Pain Measurement, RNA, Messenger metabolism, Receptors, Neurokinin-1 genetics, Receptors, Neurokinin-1 metabolism, Spinal Cord pathology, Urinary Bladder Diseases pathology, Urothelium drug effects, Urothelium pathology, Calcium Channels, T-Type metabolism, Cystathionine gamma-Lyase metabolism, Pain etiology, Signal Transduction drug effects, Substance P toxicity, Urinary Bladder Diseases chemically induced, Urinary Bladder Diseases complications
Abstract

Hydrogen sulfide (H 2 S) formed by cystathionine-γ-lyase (CSE) enhances the activity of Ca v 3.2 T-type Ca 2+ channels, contributing to the bladder pain accompanying hemorrhagic cystitis caused by systemic administration of cyclophosphamide (CPA) in mice. Given clinical and fundamental evidence for the involvement of the substance P/NK 1 receptor systems in bladder pain syndrome (BPS)/interstitial cystitis (IC), we created an intravesical substance P-induced bladder pain model in mice and analyzed the possible involvement of the CSE/Ca v 3.2 pathway. Bladder pain/cystitis was induced by i.p. CPA or intravesical substance P in female mice. Bladder pain was evaluated by counting nociceptive behavior and by detecting referred hyperalgesia in the lower abdomen and hindpaw. The isolated bladder tissue was weighed to estimate bladder swelling and subjected to histological observation and Western blotting. Intravesical substance P caused profound referred hyperalgesia accompanied by little bladder swelling or edema 6-24 h after the administration, in contrast to i.p. CPA-induced nociceptive behavior/referred hyperalgesia with remarkable bladder swelling/edema and urothelial damage. The bladder pain and/or cystitis symptoms caused by substance P or CPA were prevented by the NK 1 receptor antagonist. CSE in the bladder was upregulated by substance P or CPA, and the NK 1 antagonist prevented the CPA-induced CSE upregulation. A CSE inhibitor, a T-type Ca 2+ channel blocker and gene silencing of Ca v 3.2 abolished the intravesical substance P-induced referred hyperalgesia. The intravesical substance P-induced pain in mice is useful as a model for nonulcerative BPS, and involves the activation of the NK 1 receptor/CSE/H 2 S/Ca v 3.2 cascade., (Copyright © 2018 Elsevier Ltd. All rights reserved.)

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results